Medpace Clinical Pharmacology Unit
Medpace Clinical Pharmacology Unit
Cincinnati, Ohio, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Active, not recruiting | Phase 1 | 2026-05-06 | NCT06738017 | |
| A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-05-04 | NCT07219589 | |
| First in Human Dose Escalation Study Evaluating the Safety and Immunogenicity of IVT's Shigella-04 Vaccine in Healthy Young Adults | Bacterial Infections and Mycoses, Digestive System Diseases, Enterobacteriaceae Infections, Infections, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, bacterial infectious disease, diarrheal disease, digestive system disorder, dysentery, gastroenteritis, gram-negative bacterial infections, intestinal disorder, shigellosis | Recruiting | Phase 1 | 2025-11-19 | NCT07205926 |